Cannabis Science Inc. Cannabis Science Inc.
Cannabis Science Inc. Cannabis Science Inc.
  • Home
  • About Us
    • Corporate Overview
    • Mission Statement
    • Cannabis Science Team
    • Careers & Corporate Culture
  • iCannabinoid
    • Join Now!
  • R&D
    • The Science of Cannabinoids
    • CBIS Cannabinoid Research
    • Critical Ailments
  • COLLABORATIONS & PROJECTS
    • CBIS Medical Consortium
    • Global Economic Development
    • Pan African A & C University
    •     African Economic Initiative
    • American States University
    •     North American Economic Initiative
    • Dana-Farber
    • CFA
    • Stellenbosch University
    • CBIS Bottle It
  • Products & Pharmacies
    • Products
    • Order Online
    • Pharmacies
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
  • Media
    • CBIS News Releases
    • CBIS In The News
    • CBIS Events
  • Contact

latest Articles

  • Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
  • Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
  • Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
  • Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
  • Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

  1. Home

Total: 448 results found.

Page 15 of 23

Cannabis Science, Inc. (CBIS) Featured in A&U Magazine Regarding Potential Utility of Cannabinoids to Address Emerging Crisis of HIV Drug Resistance

Created on 2018-06-11 18:28:20

Cannabis Science, Inc. (CBIS) Promotes Robert Kane to Chief Financial Officer (CFO), Board of Directors

Created on 2018-06-11 18:27:19

Cannabis Science, Inc. (CBIS) Announces Broad Patent Licensing Agreement with Endocan Corporation (ENDO) to Develop the Cannabinoid-Based Patent N2010968 'Composition for the Treatment of Neurobehavioral Disorders' for Over-the-Counter, Dispensary, and Fo

Created on 2018-06-11 18:26:13

Cannabis Science Working with Cannabis Caucus in the U.S. House of Representatives in the Fight to Level the Playing Field for Cannabis Drug Research and Development

Created on 2018-06-11 18:24:34

Cannabis Science Enthused With CNN Monitoring The Outcome Of The National State By State Voting To Legalize Medical Cannabis

Created on 2018-06-11 18:14:37

Cannabis Science Enthused With CNN Monitoring The Outcome Of The National State By State Voting To Legalize Medical Cannabis

Created on 2018-06-11 18:14:13

Cannabis Science Announces Corporate Changes, Appointing Raymond Dabney As President And CEO And Dr. Dorothy Bray As Scientific Advisory Board Chair And Clinical Development Consultant

Created on 2018-06-11 18:13:20

Cannabis Science, Inc. (CBIS) is in the Final Stages to Acquire A British Columbia Company That Has Submitted "Marihuana For Medical Purposes" Application to Health Canada (As Previously Announced)

Created on 2018-06-11 18:12:21

Demand For Cannabis Science Drug Increases As Company Moves Into 2nd Stage Of Protocols For Pre-Clinical Drug Development, Thanks To Positive Laboratory Results From Its Operations In Spain

Created on 2018-06-11 18:11:16

Cannabis Science Advances its Move into African Market from HIV to Cancer to the Ebola Virus With a Series of High-Level Meetings in Washington, D.C.

Created on 2018-06-11 18:09:41

Cannabis Science (CBIS) Purchases Two Parcels of Cannabis Production Land from Apothecary Genetics, a Combined Total of 51 Acres; Licenses Land, Cultivation, and Formulation Usage in Major Growth Plan in California

Created on 2018-06-11 18:07:47

Cannabis Science (CBIS) Readies To Launch New Products In California With Apothocary Genetics

Created on 2018-06-11 18:06:28

Cannabis Science (CBIS) Joins Forces With The Constituency For Africa (CFA) To Focus On Improving Healthcare Infrastructure In Africa In 2015

Created on 2018-06-11 18:04:33

Cannabis Science (CBIS) Congratulates U.S. Congress for Historical Move to Stop the Department of Justice (DOJ) Impeding Legal State Medical Cannabis Operations; Perfect Timing for CBIS Large Investment in California

Created on 2018-06-11 18:03:21

After Unveiling Its Products At Premiere Global Cannabis Event, Cannabis Science, Inc. Reports Strong Customer Interest

Created on 2018-06-11 17:50:04

Cannabis Science (CBIS) Names Investor Relations Veteran Of Leading Companies To Head Its Investor Relations Initiatives

Created on 2018-06-11 17:48:40

Cannabis Science (CBIS) Accepted To Present at ICAR 2015

Created on 2018-06-11 17:47:07

CBIS Expands Licensing Deal with Purple Haze Properties as it Launches 'Jimi's Cannabis Collection' Today at the Chicago 'Marijuana Business Conference and Expo'

Created on 2018-06-11 17:44:21

Cannabis Science Brings CS-TATI-1 to the FDA with Historic Collaborative Drug Development Deal With IGXBio and Its GenePro®, a DNA-Based Immunotherapeutic that Recently Received FDA Approval to Enter into Human Trials

Created on 2018-06-11 17:42:22

Cannabis Science Signs Research & Distribution Agreement for California and Announces Guidance for Its New Product Releases in California and International Cannabinoid Research Operations

Created on 2018-06-11 17:40:14

  • Start
  • Prev
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next
  • End
REACH US.

2019 US Federal Contractor

DUNS number: 830406356
CAGE code: 5FZM9

NAICS Codes selected:

541711 - Research and Development in Biotechnology

621511 - Medical Laboratories

624230 - Emergency And Other Relief Services

Contact.

Cannabis Science Inc.

Mr. Raymond C. Dabney
President & CEO

raymond.dabney@cannabisscience.com



 
 
Copyright © 2019 Cannabis Science Inc. All Rights Reserved.